A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection

This study is ongoing, but not recruiting participants.

Study NCT00000652. Last updated on July 29, 2008. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000652

Locations


United States, California
	Children's Hosp of Los Angeles/UCLA Med Ctr
	Los Angeles, California, United States, 900276016

Sponsors and Collaborators

National Cancer Institute (NCI)

Investigators


Study Chair:	PA Pizzo

Study Chair:	RN Husson